Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C19H21N3O.ClH |
| Molecular Weight | 343.85 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CN(C)CCN1N=C(CC2=CC=CC=C2)C3=C(C=CC=C3)C1=O
InChI
InChIKey=PZSBWKCWXLBRCY-UHFFFAOYSA-N
InChI=1S/C19H21N3O.ClH/c1-21(2)12-13-22-19(23)17-11-7-6-10-16(17)18(20-22)14-15-8-4-3-5-9-15;/h3-11H,12-14H2,1-2H3;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C19H21N3O |
| Molecular Weight | 307.3895 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/1973126
Sources: https://www.ncbi.nlm.nih.gov/pubmed/1973126
Talastine (trade name Ahanon), an alkylamine H1-antihistamine, was studied as a reason for an allergic drug exanthema.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:49:28 GMT 2025
by
admin
on
Mon Mar 31 18:49:28 GMT 2025
|
| Record UNII |
SBH6TU2VU4
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB04668MIG
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
PRIMARY | |||
|
167517
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
PRIMARY | |||
|
DTXSID40167267
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
PRIMARY | |||
|
SBH6TU2VU4
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
PRIMARY | |||
|
100000084769
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
PRIMARY | |||
|
16188-76-4
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
PRIMARY | |||
|
C95238
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
PRIMARY | |||
|
m1260
Created by
admin on Mon Mar 31 18:49:28 GMT 2025 , Edited by admin on Mon Mar 31 18:49:28 GMT 2025
|
PRIMARY | Merck Index |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |